Scientists turn protein-making errors in cancer cells into a targeted kill switch

A recent Nature study investigated whether a protein-building glitch in cancer cells can be turned into a targeted cancer therapy.

Ribosomes read mRNA in groups of three genetic letters, known as codons. To find out where this reading process goes wrong, the researchers developed high-throughput dual-luciferase reporter libraries containing randomized genetic sequences. This allowed them to systematically track instances where ribosomes slipped out of their usual reading frame.

The ribosome profiler pinpointed specific codon pairs, such as AGAACG, that frequently trigger ribosomes to slip backward by one letter (a −1 frameshift) in cancer cells. Noncancerous cells, however, read these sequences normally.

Sign up for Blog Updates